The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

 

Core Laboratories NV

NYSE: CLB
Last

(U.S.) $116.83

Today's change0.00 0.00%
Updated September 3 4:05 PM EDT. Delayed by at least 15 minutes.
 

Core Laboratories NV

NYSE: CLB
Last

(U.S.) $116.83

Today's change0.00 0.00%
Updated September 3 4:05 PM EDT. Delayed by at least 15 minutes.

Core Laboratories NV closed at (U.S.)$116.83.

Over the last five days, shares have gained 7.87%, but are currently unchanged over the last year to date. Shares have underperformed the S&P 500 by 24.25% during the last year.

Key company metrics

  • Open(U.S.) $0.00
  • Previous close(U.S.) $116.83
  • High--
  • Low--
  • Bid / Ask(U.S.) $85.00 / (U.S.) $121.22
  • YTD % change-2.92%
  • Volume0
  • Average volume (10-day)845,036
  • Average volume (1-month)659,227
  • Average volume (3-month)623,636
  • 52-week range(U.S.) $87.27 to (U.S.) $160.67
  • Beta1.15
  • Trailing P/E25.77×
  • P/E 1 year forward34.84×
  • Forward PEG1.94×
  • Indicated annual dividend(U.S.) $2.20
  • Dividend yield1.88%
  • Trailing EPS(U.S.) $4.53
Updated September 3 4:05 PM EDT. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+20.48%

Based on its net profit margin of 20.48%, Core Laboratories NV is among the more effective companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX0.00%Sector:EnergyIndustry:Oil Related Services & Equipment
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q2/2015Q1/2015Q4/2014Q3/2014
Fiscal Quarter Endvalues in (U.S.) $ millions unless otherwise notedJun 30, 201506/30/2015Mar 31, 201503/31/2015Dec 31, 201412/31/2014Sep 30, 201409/30/2014
Revenue204214279276
Total other revenue--------
Total revenue204214279276
Gross profit6969110109
Total cost of revenue135144169167
Total operating expense156171188187
Selling / general / administrative13131212
Research & development--------
Depreciation / amortization7777
Interest expense (income), net operating--------
Unusual expense (income)0700
Other operating expenses, total10-10
Operating income48439089
Interest income (expense), net non-operating-3-2-3-3
Gain (loss) on sale of assets--------
Other--------
Income before tax45408887
Income after tax35316767
Income tax, total1092120
Net income35316666
Total adjustments to net income--------
Net income before extra. items35316666
Minority interest00-10
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items35316666
Inc. avail. to common incl. extra. items35316666
Diluted net income35316666
Dilution adjustment--------
Diluted weighted average shares43434444
Diluted EPS excluding extraordinary itemsvalue per share0.810.721.511.50
Dividends per sharevalue per share0.550.550.500.50
Diluted normalized EPSvalue per share0.800.851.511.49